Treatment for systemic sclerosis-associated interstitial lung disease

Volume: 33, Issue: 3, Pages: 240 - 248
Published: Mar 17, 2021
Abstract
Purpose of review This review provides an overview of the current treatments for systemic sclerosis-interstitial lung disease (SSc-ILD) and proposes a conceptual framework for disease management with case scenarios. Recent findings Broad treatment categories include traditional cytotoxic therapies, biologic disease-modifying rheumatic drugs, antifibrotic agents, autologous hematopoietic stem cell transplant, and lung transplantation. The optimal...
Paper Details
Title
Treatment for systemic sclerosis-associated interstitial lung disease
Published Date
Mar 17, 2021
Volume
33
Issue
3
Pages
240 - 248
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.